Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Funder

Showing results (111-120 of 356) with videos related to

Pageof 36
Sort By:
European Journal of Pharmacology|January 8, 1985
A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomyD Jefferys, J Boublik, J W Funder
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
SC 23992: radioreceptor assays for therapeutic and side effectsJ W Funder, J Mercer, J Hood
European Journal of Pharmacology|August 17, 1984
Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomyD Jefferys, D Copolov, J W Funder
Clinical and Experimental Pharmacology & Physiology|January 1, 1987
High-affinity aldosterone binding in rat liver--a re-evaluationA Zaini, P Pearce, J W Funder
Molecular and Cellular Endocrinology|February 1, 1989
Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxineC Sernia, J A Clements, J W Funder
Clinical and Experimental Pharmacology & Physiology|July 1, 1984
Further studies on neomycin and experimental hypertensionD Fraillon, K N Wynne, J W Funder
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Distinguishing the antihypertensive and electrolyte effects of eplerenoneD G Levy, R Rocha, J W Funder
The American Journal of Medicine|November 1, 1972
Subcellular mechanisms in the action of adrenal steroidsD Feldman, J W Funder, I S Edelman
Endocrinology|April 1, 1973
Glucocorticoid receptors in rat kidney: the binding of tritiated-dexamethasoneJ W Funder, D Feldman, I S Edelman
Endocrinology|May 1, 1973
Evidence for a new class of corticosterone receptors in the rat kidneyD Feldman, J W Funder, I S Edelman
Pageof 36

Showing results (111-120 of 356) with videos related to

Sort By:
Pageof 36
European Journal of Pharmacology|January 8, 1985
A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomyD Jefferys, J Boublik, J W Funder
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
SC 23992: radioreceptor assays for therapeutic and side effectsJ W Funder, J Mercer, J Hood
European Journal of Pharmacology|August 17, 1984
Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomyD Jefferys, D Copolov, J W Funder
Clinical and Experimental Pharmacology & Physiology|January 1, 1987
High-affinity aldosterone binding in rat liver--a re-evaluationA Zaini, P Pearce, J W Funder
Molecular and Cellular Endocrinology|February 1, 1989
Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxineC Sernia, J A Clements, J W Funder
Clinical and Experimental Pharmacology & Physiology|July 1, 1984
Further studies on neomycin and experimental hypertensionD Fraillon, K N Wynne, J W Funder
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Distinguishing the antihypertensive and electrolyte effects of eplerenoneD G Levy, R Rocha, J W Funder
The American Journal of Medicine|November 1, 1972
Subcellular mechanisms in the action of adrenal steroidsD Feldman, J W Funder, I S Edelman
Endocrinology|April 1, 1973
Glucocorticoid receptors in rat kidney: the binding of tritiated-dexamethasoneJ W Funder, D Feldman, I S Edelman
Endocrinology|May 1, 1973
Evidence for a new class of corticosterone receptors in the rat kidneyD Feldman, J W Funder, I S Edelman
Pageof 36